IDH-mutated astrocytomas typically contain IDH1/2 mutations without 1p/19q codeletion, as well as frequent TP53 mutations and ATRX loss, leading to progression to secondary glioblastomas with distinct epigenetic profiles [15]. The gene discussed is IDH2; the disease is glioblastoma.